Patent ID: 9371393
Filing Date: 2016-06-21
CPC Classification: A61K,A61P,C07K

Claim Text:
1. An immunoconjugate comprising: a) a chimeric, humanized or human Class I anti-CEA antibody or fragment thereof, wherein the Class I anti-CEA antibody or fragment thereof comprises the light chain variable region CDR sequences SASSRVSYIH (SEQ ID NO:1); GTSTLAS (SEQ ID NO:2); and QQWSYNPPT (SEQ ID NO:3); and the heavy chain variable region CDR sequences DYYMS (SEQ ID NO:4); FIANKANGHTTDYSPSVKG (SEQ ID NO:5); and DMGIRWNFDV (SEQ ID NO:6); and b) a drug or toxin conjugated to the antibody or fragment thereof.